TotalMarketCap

Impact Biomedical

IBONYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$37.592 M

$4.40 +7.32%

Close of 6 Nov 2026

As of 6 Nov 2026, Impact Biomedical (IBO) has a market capitalization of $37.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$32.0K

#3596 by revenue

Earnings

-$11.8M

Loss-making

Shares outstanding

107,821,231

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #352Elicio TherapeuticsELTX$38.1M
  2. #353Grace TherapeuticsGRCE$37.7M
  3. #354Impact BiomedicalIBO$37.6M
  4. #355Aldeyra TherapeuticsALDX$36.7M
  5. #356VeruVERU$35.0M

What if Impact Biomedical were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,305,002

Per share 751,137× higher

Bitcoin $1.53T

$178,827.89

Per share 40,643× higher

Apple $5.02T

$587,075.26

Per share 133,426× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Impact Biomedical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.